Quarterly report pursuant to Section 13 or 15(d)


9 Months Ended
Aug. 31, 2018
Inventory Disclosure [Abstract]  

Note 3 – Inventory

Inventory is comprised of public cord blood banking specimens, collection kits, finished goods, work-in-process and raw materials. Collection kits are used in the collection and processing of umbilical cord blood and cord tissue stem cells, finished goods include products purchased or assumed for resale and for the use in the Company’s processing and storage service. Inventory in the Public Cord Blood Bank includes finished goods that are specimens that are available for resale. The Company considers inventory in the Public Cord Blood Bank that has not completed all testing to determine viability to be work in process. The components of inventory at August 31, 2018 and November 30, 2017 are as follows:


     As of August 31,
     As of November 30,

Raw materials

   $ —        $ —    


     132,506        97,210  

Work-in-process – Public Bank

     14,296        —    

Finished goods

     168,052        210,854  

Finished goods – Public Bank

     15,835,197        —    

Collection kits

     27,724        14,220  

Inventory reserve

     (7,718      (7,718







Total inventory

   $ 16,170,057      $ 314,566